New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Updated February 2nd, 2022

New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer. An expert tells SurvivorNet that in esophageal cancer, anything that improves survival in patients whose disease already progresses after chemotherapy is remarkable.

NOW
PLAYING
Golf Ball-Sized Mass Discovered In 35-Year-Old Dad & Non-Smoker Diagnosed With Late-Stage Lung Cancer After Dry Cough
NOW
PLAYING
Charlotte Mom, 49, Saved By Experimental Life Saving Medicine, Thriving 12-Years Later: Guide To Accessing Clinical Trials
NOW
PLAYING
Heart Singer Ann Wilson's Cancer Diagnosis Comes Just After Reuniting With Sister Nancy; She Assures Fans Postponed Tour Dates are Just a 'Pause'
NOW
PLAYING
Back in Spotlight, Incredibly Youthful Newsman John Stossel, 77, Beat Lung Cancer & Quickly Returned To Work— Early Detection Is Key
NOW
PLAYING
More Progress With Less Intensive Treatment, Crucial New Research For People Battling Cancers Like Ovarian, Esophageal, & Hodgkin Lymphoma
NOW
PLAYING
'Dance Moms' Alum Kelly Hyland, 53, Praised As 'Strongest Woman I Know' By Daughters Amid Breast Cancer Diagnosis

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... esophageal cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider